Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $132.67 billion. The enterprise value is $146.90 billion.
| Market Cap | 132.67B |
| Enterprise Value | 146.90B |
Important Dates
The next confirmed earnings date is Wednesday, April 23, 2025, before market open.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 1.48B |
| Shares Outstanding | 1.48B |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 92.41% |
| Float | 1.47B |
Valuation Ratios
The trailing PE ratio is 71.76 and the forward PE ratio is 31.35. BSX's PEG ratio is 2.92.
| PE Ratio | 71.76 |
| Forward PE | 31.35 |
| PS Ratio | 8.65 |
| Forward PS | 7.04 |
| PB Ratio | 6.67 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 51.45 |
| P/OCF Ratio | 39.62 |
| PEG Ratio | 2.92 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.39, with an EV/FCF ratio of 55.54.
| EV / Earnings | 79.27 |
| EV / Sales | 8.77 |
| EV / EBITDA | 34.39 |
| EV / EBIT | 48.93 |
| EV / FCF | 55.54 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.08 |
| Quick Ratio | 0.46 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.57 |
| Debt / FCF | 4.24 |
| Interest Coverage | 9.84 |
Financial Efficiency
Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 6.02%.
| Return on Equity (ROE) | 8.89% |
| Return on Assets (ROA) | 5.03% |
| Return on Invested Capital (ROIC) | 6.02% |
| Return on Capital Employed (ROCE) | 9.10% |
| Revenue Per Employee | $315,981 |
| Profits Per Employee | $34,962 |
| Employee Count | 53,000 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, BSX has paid $436.00 million in taxes.
| Income Tax | 436.00M |
| Effective Tax Rate | 19.11% |
Stock Price Statistics
The stock price has increased by +32.76% in the last 52 weeks. The beta is 0.73, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +32.76% |
| 50-Day Moving Average | 101.82 |
| 200-Day Moving Average | 88.64 |
| Relative Strength Index (RSI) | 29.26 |
| Average Volume (20 Days) | 8,632,244 |
Short Selling Information
The latest short interest is 12.62 million, so 0.85% of the outstanding shares have been sold short.
| Short Interest | 12.62M |
| Short Previous Month | 11.46M |
| Short % of Shares Out | 0.85% |
| Short % of Float | 0.86% |
| Short Ratio (days to cover) | 1.48 |
Income Statement
In the last 12 months, BSX had revenue of $16.75 billion and earned $1.85 billion in profits. Earnings per share was $1.25.
| Revenue | 16.75B |
| Gross Profit | 11.46B |
| Operating Income | 3.00B |
| Pretax Income | n/a |
| Net Income | 1.85B |
| EBITDA | 4.27B |
| EBIT | 3.00B |
| Earnings Per Share (EPS) | $1.25 |
Balance Sheet
The company has $414.00 million in cash and $11.23 billion in debt, giving a net cash position of -$10.81 billion or -$7.31 per share.
| Cash & Cash Equivalents | 414.00M |
| Total Debt | 11.23B |
| Net Cash | -10.81B |
| Net Cash Per Share | -$7.31 |
| Equity (Book Value) | 22.00B |
| Book Value Per Share | 14.76 |
| Working Capital | 521.00M |
Cash Flow
In the last 12 months, operating cash flow was $3.44 billion and capital expenditures -$790.00 million, giving a free cash flow of $2.65 billion.
| Operating Cash Flow | 3.44B |
| Capital Expenditures | -790.00M |
| Free Cash Flow | 2.65B |
| FCF Per Share | $1.79 |
Margins
Gross margin is 68.41%, with operating and profit margins of 17.93% and 11.07%.
| Gross Margin | 68.41% |
| Operating Margin | 17.93% |
| Pretax Margin | 13.63% |
| Profit Margin | 11.07% |
| EBITDA Margin | 25.50% |
| EBIT Margin | 17.93% |
| FCF Margin | 15.79% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | 1.36% |
| FCF Yield | 1.94% |
Analyst Forecast
The average price target for BSX is $107.23, which is 19.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $107.23 |
| Price Target Difference | 19.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (5Y) | 10.40% |
| EPS Growth Forecast (5Y) | 29.07% |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 4.66 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.66 |
| Piotroski F-Score | 5 |